Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
Prelude Therapeutics (PRLD) Ownership Overview
39.52% Insiders
3.03% Mutual Funds
33.70% Other Institutional Investors
1.38% ETFs
22.37% Public Companies and
Individual Investors
The ownership structure of Prelude Therapeutics (PRLD) stock is a mix of institutional, retail, and individual investors. Approximately 38.11% of the company’s stock is owned by Institutional Investors, 39.52% is owned by Insiders, and 22.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 27, 2025 | xxxxxxxxxxxxx | $465750 | |
Mar 24, 2025 | xxxxxxxxxxxxx | $14850 | |
Mar 18, 2025 | xxxxxxxxxxxxx | $29238 | |
Mar 14, 2025 | xxxxxxxxxxxxx | $69225 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,646,056 | Insider | 16.93% | 17,565,992 | |
| 10,123,824 | Institution | 16.10% | 16,704,310 | |
| 9,252,951 | Insider | 14.72% | 15,267,369 | |
| 3,669,054 | Insider | 5.84% | 6,053,939 | |
| 927,934 | Institution | 1.48% | 1,531,091 | |
| 867,018 | Institution | 1.38% | 1,430,580 | |
| 661,222 | Institution | 1.05% | 1,091,016 | |
| 500,098 | Insider | 0.80% | 825,162 | |
| 480,123 | Insider | 0.76% | 792,203 | |
| 185,624 | Institution | 0.30% | 306,280 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 927,934 | Institution | 1.48% | 1,531,091 | |
| 661,222 | Institution | 1.05% | 1,091,016 | |
| 185,624 | Institution | 0.30% | 306,280 | |
| 85,000 | Institution | 0.14% | 140,250 | |
| 17,428 | Institution | 0.03% | 28,756 | |
| 13,804 | Institution | 0.02% | 22,777 | |
| 6,792 | Institution | 0.01% | 11,207 | |
| 2,571 | Institution | <0.01% | 4,242 | |
| 1,922 | Institution | <0.01% | 3,171 | |
| 187 | Institution | <0.01% | 309 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 705,018 | Institution | 1.12% | 1,120,979 | |
| 162,000 | Institution | 0.26% | 257,580 | |
| 15,986 | Institution | 0.03% | 38,207 |
FAQ
Who Owns Prelude Therapeutics (PRLD)?
According to the latest TipRanks data, approximately 33.70% of the company's stock is held by institutional investors, 39.52% is held by insiders, and 22.37% is held by retail investors.
What percentage of Prelude Therapeutics (PRLD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.70% of Prelude Therapeutics (PRLD) stock is held by institutional investors.
What percentage of Prelude Therapeutics (PRLD) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.37% of Prelude Therapeutics (PRLD) stock is held by retail investors.
Who owns the most shares of Prelude Therapeutics (PRLD)?
David Bonita owns the most shares of Prelude Therapeutics (PRLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.